Publications

456 publications

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
You can select a specific type of a publication you are looking for, such as press releases or speeches
Sort by:
  1. Zinnige Zorg in-depth phase appropriate post-treatment surveillance of patients with non-melanoma skin cancer or actinic keratosis - letter to Minister

    As part of the Zinnige Zorg programme, the National Health Care Institute started the in-depth phase of appropriate ...

    Letter | 24-10-2018

  2. Zinnige Zorg in-depth phase report appropriate post-treatment surveillance of patients with non-melanoma skin cancer or actinic keratosis

    As part of the Zinnige Zorg programme, the National Health Care Institute started the in-depth phase of appropriate ...

    Report | 24-10-2018

  3. Package advice in practice - Deliberations for arriving at a fair package

    The public debate pays a lot of attention to how we can continue to pay for health care in the future. A question that the ...

    Report | 11-09-2018

  4. Semaglutide (Ozempic®) for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise

    The National Health Care Institute carried out a marginal assessment of whether semaglutide (Ozempic®) is interchangeable with a ...

    Report | 28-08-2018

  5. Working method for the Zinnige Zorg (appropriate care) Programme

    The National Health Care Institute’s motto is "Taking care of good health care: no more and no less than necessary". Every ...

    Brochure | 27-08-2018

  6. Zinnige Zorg implementation of the appropriate care of expensive drugs in cases of castration-refractory prostate cancer (CRPC)

    This letter is to inform the Minister of Medical Care and Sport about the changes made by parties during the implementation phase ...

    Letter | 23-08-2018

  7. Hydrocortisone sodium phosphate (Softacor®) for the treatment of mild non-infectious allergic or inflammatory conjunctival diseases

    Zorginstituut Nederland has carried out an assessment of the medicinal product hydrocortisone sodium phosphate (Softacor®) can be ...

    Report | 06-08-2018

  8. Zinnige Zorg room for improvement analysis: Peripheral Arterial Disease

    This Room for Improvement Analysis describes the research and the resulting actions and agreements that focus on further ...

    Report | 01-08-2018

  9. Roflumilast (Daxas®) for maintenance treatment of severe chronic obstructive lung disease (COPD)

    The National Health Care Institute has carried out an assessment of whether roflumilast (Daxas®) is interchangeable with a drug ...

    Report | 31-07-2018

  10. SGLT2 inhibitors for the treatment of type 2 diabetes: relaxing List 2 conditions

    The National Health Care Institute has carried out a substantive assessment of whether the existing list 2 conditions for SGLT2 ...

    Report | 31-07-2018